SCHEMBL12926432

SCHEMBL12926432

FCc1ccc(CNc2ccc(Cc3c[nH]c4ncccc34)cn2)cn1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 4/20 0.71
KIT P10721 3/20 0.71
CYP3A4 P08684 10/20 0.54
CYP2C19 P33261 6/20 0.54
CYP2D6 P10635 1/20 0.54
LCK P06239 1/20 0.52
PGR P06401 1/20 0.52
CHRM2 P08172 1/20 0.52
HTR1A P08908 1/20 0.52
ADRA2A P08913 1/20 0.52
PDGFRB P09619 1/20 0.52
ADORA3 P0DMS8 1/20 0.52
CHRM1 P11229 1/20 0.52
PDGFRA P16234 1/20 0.52
FLT1 P17948 1/20 0.52
DRD1 P21728 1/20 0.52
TBXA2R P21731 1/20 0.52
SLC6A2 P23975 1/20 0.52
ADORA1 P30542 1/20 0.52
SLC6A4 P31645 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12646996 0.90 CSF1R (0.78) CSF1RKITCYP3A4CYP2C19CYP2D6
SCHEMBL19898655 0.88 CSF1R (0.74) CSF1RKITCYP3A4CYP2C19CYP2D6
SCHEMBL14236232 0.87 CYP3A4 (0.62) CSF1RKITCYP3A4CYP2C19KDR
SCHEMBL1267815 0.87 CSF1R (0.73) CSF1RKITCYP3A4CYP2C19CYP2D6
SCHEMBL1267693 0.86 CSF1R (0.67) CSF1RKITCYP3A4CYP2C19CYP2D6
SCHEMBL1267073 0.86 CSF1R (0.78) CSF1RKITCYP3A4CYP2C19CYP2D6
SCHEMBL878907 0.85 CSF1R (0.78) CSF1RKITCYP3A4CYP2C19CYP2D6
SCHEMBL1889408 0.85 CYP3A4 (0.73) CSF1RKITCYP3A4CYP2C19CYP2D6
SCHEMBL1267263 0.84 CSF1R (0.79) CSF1RKITCYP3A4CYP2C19CYP2D6
SCHEMBL19898775 0.84 CSF1R (0.67) CSF1RKITCYP3A4CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893075-B2 Compounds modulating c-fms and/or c-kit activity and uses therefor PLEXXIKON, INC. (US) 2011-02-22 US disclosed
US-20090076046-A1 Compounds modulating c-fms and/or c-kit activity and uses therefor PLEXXIKON INC 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076046-A1 Compounds modulating c-fms and/or c-kit activity and uses therefor KIT, FLT3, FLT1 CSF1R 4/4885KIT 1/4885CYP3A4 3847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.